447 related articles for article (PubMed ID: 17589499)
21. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
22. NSD family proteins: Rising stars as therapeutic targets.
He L; Cao Y; Sun L
Cell Insight; 2024 Apr; 3(2):100151. PubMed ID: 38371593
[TBL] [Abstract][Full Text] [Related]
23. NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome.
Brennan K; Zheng H; Fahrner JA; Shin JH; Gentles AJ; Schaefer B; Sunwoo JB; Bernstein JA; Gevaert O
Hum Mol Genet; 2022 Jul; 31(13):2164-2184. PubMed ID: 35094088
[TBL] [Abstract][Full Text] [Related]
24. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract][Full Text] [Related]
25. Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1.
Martin-Herranz DE; Aref-Eshghi E; Bonder MJ; Stubbs TM; Choufani S; Weksberg R; Stegle O; Sadikovic B; Reik W; Thornton JM
Genome Biol; 2019 Aug; 20(1):146. PubMed ID: 31409373
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
Michmerhuizen NL; Klco JM; Mullighan CG
Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
[TBL] [Abstract][Full Text] [Related]
27. [Acute myeloid leukemia with NUP98 gene rearrangement: a report of 5 cases].
Gao JJ; Dong F; Zhao W; Zhang ZH; Wang YF; Zhu MX; Wang J; Jing HM; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):866-867. PubMed ID: 38049343
[No Abstract] [Full Text] [Related]
28. NSD1 deposits histone H3 lysine 36 dimethylation to pattern non-CG DNA methylation in neurons.
Hamagami N; Wu DY; Clemens AW; Nettles SA; Gabel HW
bioRxiv; 2023 Feb; ():. PubMed ID: 36824816
[TBL] [Abstract][Full Text] [Related]
29. Histone methylation mediated by NSD1 is required for the establishment and maintenance of neuronal identities.
Zheng Y; Zhao C; Song Q; Xu L; Zhang B; Hu G; Kong X; Li S; Li X; Shen Y; Zhuang L; Wu M; Liu Y; Zhou Y
Cell Rep; 2023 Dec; 42(12):113496. PubMed ID: 37995181
[TBL] [Abstract][Full Text] [Related]
30. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
[TBL] [Abstract][Full Text] [Related]
31. Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation.
Waraky A; Östlund A; Nilsson T; Weichenhan D; Lutsik P; Bähr M; Hey J; Tunali G; Adamsson J; Jacobsson S; Morsy MHA; Li S; Fogelstrand L; Plass C; Palmqvist L
Haematologica; 2024 Mar; 109(3):725-739. PubMed ID: 37317878
[TBL] [Abstract][Full Text] [Related]
32. Retroviral insertional mutagenesis identifies oncogene cooperation.
Nakamura T
Cancer Sci; 2005 Jan; 96(1):7-12. PubMed ID: 15649248
[TBL] [Abstract][Full Text] [Related]
33. H3K36 methylation maintains cell identity by regulating opposing lineage programmes.
Hoetker MS; Yagi M; Di Stefano B; Langerman J; Cristea S; Wong LP; Huebner AJ; Charlton J; Deng W; Haggerty C; Sadreyev RI; Meissner A; Michor F; Plath K; Hochedlinger K
Nat Cell Biol; 2023 Aug; 25(8):1121-1134. PubMed ID: 37460697
[TBL] [Abstract][Full Text] [Related]
34. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract][Full Text] [Related]
35. NUP98 and RAE1 sustain progenitor function through HDAC-dependent chromatin targeting to escape from nucleolar localization.
Neely AE; Blumensaadt LA; Ho PJ; Lloyd SM; Kweon J; Ren Z; Bao X
Commun Biol; 2023 Jun; 6(1):664. PubMed ID: 37353594
[TBL] [Abstract][Full Text] [Related]
36. The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation.
Rona GB; Almeida DSG; Pinheiro AS; Eleutherio ECA
Oncotarget; 2017 Aug; 8(33):54068-54081. PubMed ID: 28903324
[TBL] [Abstract][Full Text] [Related]
37. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
[TBL] [Abstract][Full Text] [Related]
38. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
39. Cancers and the NSD family of histone lysine methyltransferases.
Morishita M; di Luccio E
Biochim Biophys Acta; 2011 Dec; 1816(2):158-63. PubMed ID: 21664949
[TBL] [Abstract][Full Text] [Related]
40. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
